caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1831180546

Samuel MyrickMD

PRACTICEOCALA ONCOLOGY CENTER PLSee all providers at this practice →
Medical OncologyOcala, FLI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
3,329
Unique beneficiaries
—
Total services
100,703
Distinct HCPCS
59
Medicare payment
$1.2M
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 212 Medical Oncology providers in FL — top quintile (cohort median 1,224).
REFERRAL NETWORK

Where Samuel Myrick's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 21 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Laboratory Corporation Of America
Clinical Laboratory · Tampa, FL
1451,179
Rama Balaraman
Hematology-Oncology · Ocala, FL
1401,420
Maury Berger
Hematology-Oncology · Ocala, FL
124944
MUNROE HMA HOSPITAL LLC120558
Craig Reynolds
Hematology-Oncology · Ocala, FL
97990
Qamar Khan
Hematology-Oncology · Kissimmee, FL
45366
WILLARD, MARK37153
Malcolm Williamson
Diagnostic Radiology · Ocala, FL
35146
Cooley Pantazis
Pathology · Ocala, FL
29142
David Mckay
Interventional Radiology · Ocala, FL
27117
YAP, MARK27137
Ralf Barckhausen
Diagnostic Radiology · Ocala, FL
2695
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
QUALITY · MIPS · 2024
Final MIPS score
75.0
Quality
0.0
Cost
0.0
Improvement activities
0.0
Promoting interop.
0.0
Payment adjustment
0.00%
Group
PRESCRIBING · PART D · 2024
Total Rx claims
751
Beneficiaries
—
Total drug cost
$1.5M
Distinct drugs
26
Brand share
26.4%
Top prescribed drugs
Anastrozole129 claims
Prednisone60 claims
Dexamethasone58 claims
Abiraterone Acetate47 claims
Tamoxifen Citrate39 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$7K
Payment records
243
By payment type
Food and Beverage$5K
Long term medical supply or device loan$1K
Education$650